CHMP recommends approval for Averoa’s Xoanacyl, an oral therapy for chronic kidney disease: Grenoble, France Friday, April 4, 2025, 12:00 Hrs [IST] Averoa, a biopharmaceutical c ...
Therapeutics announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback